Cargando…
Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec
The discovery of EGFR tyrosine kinase inhibitors (TKI) for the treatment of EGFR mutant (EGFRm) metastatic NSCLC is regarded as a landmark in lung cancer. EGFR-TKIs have now become a standard first-line treatment for EGFRm NSCLC. The aim of this retrospective cohort study is to describe real-world p...
Autores principales: | Agulnik, Jason S., Kasymjanova, Goulnar, Pepe, Carmela, Hurry, Manjusha, Walton, Ryan N., Sakr, Lama, Cohen, Victor, Small, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700535/ https://www.ncbi.nlm.nih.gov/pubmed/34940073 http://dx.doi.org/10.3390/curroncol28060434 |
Ejemplares similares
-
Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC)
por: Agulnik, Jason S., et al.
Publicado: (2022) -
The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Center: A Retrospective Chart Review
por: Kasymjanova, Goulnar, et al.
Publicado: (2021) -
The Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer over a 2-Year Period at a Canadian Academic Center
por: Kasymjanova, Goulnar, et al.
Publicado: (2022) -
P31.01 Impact of COVID-19 on Lung Cancer Diagnosis and Treatment: A Retrospective Chart Review
por: Kasymjanova, G., et al.
Publicado: (2021) -
EP06.01-001 The Longitudinal Impact of COVID-19 on the Diagnosis and Treatment of Lung Cancer at a Canadian Academic Centre: A Retrospective Chart Review
por: Rizzolo, A., et al.
Publicado: (2022)